600 发表于 2025-3-25 06:52:20

http://reply.papertrans.cn/1/83/8257/8257-21.png

白杨 发表于 2025-3-25 09:02:13

http://reply.papertrans.cn/1/83/8257/8257-22.png

OTTER 发表于 2025-3-25 13:37:15

Submitted on: 08 November 2017.
Revised on: 22 February 2018.
Accepted on: 25 March 2018.

___________________eLife---ELIFE SCIENCES PUBL LTD

Colonoscopy 发表于 2025-3-25 19:18:53

http://reply.papertrans.cn/1/83/8257/8257-24.png

Blazon 发表于 2025-3-25 21:42:59

http://reply.papertrans.cn/1/83/8257/8257-25.png

激励 发表于 2025-3-26 00:21:49

Submitted on: 21 June 2016.
Revised on: 18 September 2016.
Accepted on: 27 October 2016.

___________________eLife---ELIFE SCIENCES PUBL LTD

粗俗人 发表于 2025-3-26 05:35:46

http://reply.papertrans.cn/1/83/8257/8257-27.png

explicit 发表于 2025-3-26 10:42:58

Submitted on: 05 September 2011.
Revised on: 19 November 2011.
Accepted on: 03 December 2011.

___________________eLife---ELIFE SCIENCES PUBL LTD

装入胶囊 发表于 2025-3-26 14:09:44

http://reply.papertrans.cn/1/83/8257/8257-29.png

打包 发表于 2025-3-26 18:47:44

http://reply.papertrans.cn/1/83/8257/8257-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊eLife 2024/2025影响因子:6.441 (ELIFE) (2050-084X). (BIOLOGY)(生物学)Science Citation Index Expanded